Cleared Traditional

K955270 - TAPE & BANDAGE, ADHESIVE

K955270 is an FDA 510(k) clearance for TAPE & BANDAGE, manufactured by Robert R. Stevens. The device is a Class 2 Cardiovascular device with product code DXC cleared through the Traditional 510(k) pathway after a 267-day FDA review.

K955270 · Robert R. Stevens · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1996
Decision
267d
Days
Class 2
Risk

K955270 is an FDA 510(k) clearance for the TAPE & BANDAGE, ADHESIVE. Classified as Clamp, Vascular (product code DXC), Class II - Special Controls.

Submitted by Robert R. Stevens (Miami Lakes, US). The FDA issued a Cleared decision on August 8, 1996 after a review of 267 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4450 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Robert R. Stevens devices

FDA 510(k) Submission Details - K955270

510(k) Number K955270 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 15, 1995
Decision Date August 08, 1996
Days to Decision 267 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
142d slower than avg
Panel avg: 125d · This submission: 267d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXC Device Classification - Class 2, Special Controls

Product Code DXC Clamp, Vascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4450
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXC Clamp, Vascular

All 171
Devices cleared under the same product code (DXC) and FDA review panel - the closest regulatory comparables to K955270.
HEARTPORT ENDOVASCULAR CARDIOPULMONARY BYPASS SYSTEM ANTEGRADE SYTEM (CATALOG NUMBER ECPB-A) ANTEGRADE/RETROGRADE SYSTEM
K962858 · Heartport, Inc. · Sep 1996
HEARTPORT ENDOAORTIC CLAMP
K962510 · Heartport, Inc. · Sep 1996
D. DEVICE II
K955742 · Yousef Daneshvar · Aug 1996
DANESHVAR'S DEVICE (MODIFICATION)
K961461 · Y. Daneshvar · Jun 1996
MICRO ANASTOMOSIS CLAMP
K961100 · R.S.P. Medical Management, Inc. · Jun 1996
HEARTPORT ENDOAORTIC CLAMP
K955132 · Heartport, Inc. · Jun 1996